Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial.
Roeker LE, Woyach JA, Cheah CYY, Coombs CC, Shah NN, Wierda WG, Patel MR, Lamanna N, Tsai DE, Nair BC, Wang C, Zhao X, Liu D, Radtke D, Chapman S, Marella N, McNeely SC, Brown JR.
Roeker LE, et al. Among authors: liu d.
Blood. 2024 Jun 11:blood.2024024510. doi: 10.1182/blood.2024024510. Online ahead of print.
Blood. 2024.
PMID: 38861666